Get Fit Bharat

Tag: Interval

HomeInterval

Medius, a leader in the automation of source-to-pay processes and expense report management, announces its registration as a Partner Dematerialization Platform (PDP) with the French Directorate General of Public Finances (DGFIP), affirming its commitment to help companies respond to the challenges of carrying out transactions in France. From 1 September …

Stock Exchange Release 17.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2024   Date 17.12.2024   Exchange transaction Buy   Share class FSKRS   Amount  2,000   Average price/share 14.3668 EUR Highest price/share 14.3800 EUR Lowest price/share 14.3400 EUR Total price 28,733.60 EUR       The …

  ALEXANDRIA GROUP OYJ NOTIFICATION     17.12.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 17.12.2024   Date 17.12.2024   Exchange transaction Buy   Share class ALEX   Amount 260   Average price/share 8.5500 EUR Highest price/share 8.5500 EUR Lowest price/share 8.5500 EUR Total price 2,223.00 …

ZenithVCI-1 listed on Nordic AIF Sweden with ISIN: SE0010820431, has changed its last trading day to December 31, 2027. For further information concerning this NGM notice please contact: Listing on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark …

Nordea Bank AbpStock exchange release – Changes in company’s own shares17.12.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 17.12.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* ** Total cost, EUR* ** XHEL …

Lund, Sweden, 17 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome (GBS) and an indirect treatment comparison of the 15-HMedIdeS-09 study data to the International …